Ptc Therapeutics (PTCT) Change in Cash (2012 - 2026)

Ptc Therapeutics' Change in Cash history runs 15 years deep, the most recent figure standing at $215.9 million for Q2 2026.

• In Q2 2026, Change in Cash rose 146.65% year-over-year to $215.9 million; the TTM figure through Jun 2026 stood at $33.3 million (down 90.88% YoY), while the FY2025 annual figure was $203.0 million, up 9.72% from the prior year.
• Change in Cash for Q2 2026 stood at $215.9 million, up from -$147.9 million in the prior quarter.
• The five-year high for Change in Cash was $700.5 million in Q1 2025, with the low at -$462.8 million in Q2 2025.
• The 5-year median for Change in Cash is -$26.1 million (2023), against an average of $48.3 million.
• The sharpest annual moves came in 2022 and 2025: Change in Cash soared 175514.0% in 2022, then tumbled 545.34% in 2025.
• Ptc Therapeutics' Change in Cash stood at $175.4 million in 2022, then soared by 144.49% to $428.9 million in 2023, then sank by 40.42% to $255.5 million in 2024, then rose by 22.11% to $312.0 million in 2025, then sank by 30.81% to $215.9 million in 2026.
• Business Quant data shows PTCT's Change in Cash at $215.9 million in Q2 2026, -$147.9 million in Q1 2026, and $312.0 million in Q4 2025.